Healthcare / Health Information ServicesHKSE
$5.57
+0.02 (+0.36%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-367.2M · quality 86.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
15/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.7B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-3.0%
↓Gross Margin
33.5%
↓Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-16.7%
FCF CAGR
—
FCF margin
-49.1%
FCF / Net income
2.98x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $715.0M · net income $-117.8M · FCF $-350.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $715.0M | $715.0M | $807.1M | $804.7M | $1.24B |
| Net Income | $-117.8M | $-117.8M | $-194.9M | $-628.0M | $-762.3M |
| EBITDA | $-89.6M | $-89.6M | $-170.8M | $-580.0M | $-715.7M |
| EPS | -0.11 | -0.11 | -0.19 | -0.63 | -0.80 |
| Gross Margin | 33.5% | 33.5% | 42.1% | 34.1% | 32.3% |
| Operating Margin | -43.0% | -43.0% | -43.7% | -74.5% | -58.3% |
| Net Margin | -16.5% | -16.5% | -24.2% | -78.0% | -61.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.02 | 0.00 | 0.01 |
| Current Ratio | 4.42 | 4.42 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-350.8M | $-350.8M | $-367.2M | $-378.2M | $-683.5M |
| Returns | |||||
| ROE | -3.0% | -3.0% | -4.8% | -15.4% | -19.1% |
| Valuation | |||||
| P/B | 1.50 | 1.50 | 1.04 | 2.00 | 2.24 |
| Growth & Yield | |||||
| Revenue Growth | -11.4% | -11.4% | 0.3% | -35.0% | — |
| EPS Growth | 42.1% | 42.1% | 69.8% | 21.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.19 → -0.11
Residual
+0.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.